SCHEMBL28064303

SCHEMBL28064303

[CH2]c1ccc(CC[SH](=O)=O)c([N+](=O)[O-])c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.37
SNCA P37840 2/20 0.36
PDK1 Q15118 1/20 0.34
ALDH1A1 P00352 5/20 0.33
TSHR P16473 5/20 0.33
TDP1 Q9NUW8 5/20 0.32
MAPT P10636 3/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALOX15 P16050 2/20 0.32
ALOX12 P18054 1/20 0.32
ALOX5 P09917 1/20 0.32
CYP3A4 P08684 3/20 0.31
HPGD P15428 2/20 0.31
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
LMNA P02545 1/20 0.31
GRIK1 P39086 1/20 0.31
GRIA1 P42261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16961402 0.79 PDK1 (0.42) CYP1A2SNCAPDK1ALDH1A1TSHR
SCHEMBL27897142 0.79 CYP1A2 (0.39) CYP1A2SNCAPDK1ALDH1A1TSHR
SCHEMBL16961286 0.79 PDK1 (0.51) CYP1A2SNCAPDK1ALDH1A1TSHR
SCHEMBL7534585 0.77 CYP1A2 (0.40) CYP1A2SNCAPDK1ALDH1A1TSHR
SCHEMBL7530158 0.77 CYP1A2 (0.40) CYP1A2SNCAPDK1ALDH1A1TSHR
SCHEMBL28531178 0.77 CYP1A2 (0.44) CYP1A2SNCAPDK1ALDH1A1TSHR
SCHEMBL28040575 0.76 CASP6 (0.58) PDK1TSHRKMT2ALMNA
SCHEMBL28160982 0.75 ALDH1A1 (0.58) ALDH1A1TSHRTDP1CYP3A4HPGD
SCHEMBL28046371 0.73 SLC6A4 (0.40) CYP1A2SNCAPDK1ALDH1A1TSHR
SCHEMBL5178027 0.72 TSHR (0.56) CYP1A2ALDH1A1TSHRTDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105579457-A Substituted N-biphenyl-3-acetylamino-benzamides and N- [3- (acetylamino) phenyl ] -biphenyl-carboxamides and their use as WNT signaling pathway inhibitors Bayer Pharma AG 2016-05-11 CN disclosed